IBRI Drives New Collaboration Model Targeting Type 2 Diabetes
December 22, 2016 11:45 ET
|
Indiana Biosciences Research Institute
INDIANAPOLIS, Ind., Dec. 22, 2016 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced a new collaboration with Eli Lilly and Company, Roche Diagnostics, the...
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
November 09, 2015 16:43 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...
Former Roche Pharmaceuticals CEO Joins Mesoblast Board of Directors
March 05, 2014 19:24 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, March 5, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that William M. Burns, former Chief...
Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Raises Price Target to $14.00
July 31, 2013 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwired - Jul 31, 2013) - Vista Partners announced today that it has updated coverage on Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) ("The Company" or "OHR") and raised its...
Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Target Price $3.50
October 17, 2012 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Oct 17, 2012) - Vista Partners announced today that it has updated coverage on Ohr Pharmaceutical, Inc. (OTCBB: OHRP) ("The Company" or "OHR") with a twelve month...
Vista Partners Publishes August 2012 Newsletter
August 08, 2012 12:34 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Aug 8, 2012) - Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of August. Each...
Vista Partners Publishes August 2012 Newsletter
August 02, 2012 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Aug 2, 2012) - Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of August. Each...
Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Raises Target Price to $3.50
August 01, 2012 09:15 ET
|
Vista Partners
SAN FRANCISCO, CA--(Marketwire - Aug 1, 2012) - Vista Partners announced today that it has updated coverage on Ohr Pharmaceutical, Inc. (OTCBB: OHRP) ("The Company" or "OHR") and raised its...